Sep 7, 2025, 11:53
Desmond Murphy Starts a New Role as U.S. Oncology Assets Liaison at Servier Pharmaceuticals
Servier Pharmaceuticals shared a post on LinkedIn:
“For more than 20 years, Des Murphy has played a key role in Servier’s international journey, navigating diverse roles across Ireland, Asia, the UK, France, and now Boston.
In his new role as U.S. Oncology Assets Liaison, Des leverages his deep oncology expertise and global leadership experience to connect teams and strategies – all with one goal in mind: delivering innovative treatments to patients.
Discover how Des’s passion for science, people, and innovation continues to shape Servier’s oncology mission around the world.
Read the full story here.”
More from Servier Pharmaceuticals on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 14:57
Sep 7, 2025, 14:41
Sep 7, 2025, 14:23
Sep 7, 2025, 14:05
Sep 7, 2025, 13:10